Category: LSHTM CTU News

Home  ›  LSHTM CTU News  ›  Page 2
The CRASH-3 Trial shows that TXA as the world first drug for TBI
The CRASH-3 Results and News
October 15, 2019 Clinical Trials,LSHTM CTU News,Tranexamic Acid (TXA),Trauma Care CTU admin

Tranexamic Acid (TXA) is a safe, low cost, and widely available drug which could prevent deaths from TBI by as much as 20% depending on severity of the injury

Details
ISTH TV on Tranexamic Acid: The importance of giving TXA early to trauma and PPH patients
ISTH TV: The importance of giving TXA early to trauma & PPH patients
July 10, 2019 LSHTM CTU News,Tranexamic Acid (TXA) CTU admin

Watch Prof Ian Roberts on International Society on Thrombosis and Hemostasis Daily News, discussing the importance of giving TXA early to trauma & PPH patients

Details
WOMAN Trial shows TXA reduces premature death for PPH patients
WOMAN Trial Results and News
April 26, 2017 Clinical Trials,Emergency Care,LSHTM CTU News,Maternal Health,Tranexamic Acid (TXA) CTU admin

Can we prevent women from dying after childbirth? The WOMAN trial showed that if given within 3 hours, TXA can reduce the risk of death due to bleeding by one third.

Details
TXA should be given as early as possible to bleeding trauma patients
The CRASH-2 Results and News
June 14, 2010 Clinical Trials,Emergency Care,LSHTM CTU News,Tranexamic Acid (TXA) CTU admin

Global trial CRASH-2 is now complete and shows new hopes to cut deaths from serious injury – a simple jab of Tranexamic Acid could save up to 100,000 lives a year.

Details